AI assistant
INSMED Inc — Director's Dealing 2024
Jan 11, 2024
30150_dirs_2024-01-11_8df250d3-edbe-4bd0-a6cf-4a480f12f883.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-01-09
Reporting Person: Flammer Martina M.D. (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-09 | Common Stock | S | 4715 | $29.01 | Disposed | 112810 | Direct |
| 2024-01-10 | Common Stock | S | 1245 | $28.90 | Disposed | 111565 | Direct |
Footnotes
F1: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F2: This is the weighted average sales price representing 4,715 shares sold at prices ranging from $28.88 to $29.10 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.